Lipid metabolism and hyperlipidemia in dogs

Veterinary Journal

Volumn 183, Issue 1, 2010, Pages 12-21

  Xenoulis, Panagiotis G ^a   Steiner, Jörg M ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Canine; Dog; Hypercholesterolemia; Hyperlipidemia; Hypertriglyceridemia

Indexed keywords

CHYLOMICRON; FISH OIL; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; BREEDING; CAUSAL ATTRIBUTION; CHOLESTASIS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DOG DISEASE; DRUG CAPSULE; ENDOCRINE DISEASE; ERYTHEMA; EYE DISEASE; HEPATOBILIARY DISEASE; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; KIDNEY DISEASE; LABORATORY TEST; LIPID ANALYSIS; LIPID METABOLISM; LIVER DISEASE; LOW FAT DIET; NONHUMAN; OBESITY; PANCREATITIS; PROTEINURIA; PRURITUS; REVIEW; TURBIDITY;

ANIMALS; ANTILIPEMIC AGENTS; DIET, REDUCING; DOG DISEASES; DOGS; FATTY ACIDS, OMEGA-3; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LIVER DISEASES; NIACIN; OBESITY; PANCREATITIS;

CANIS FAMILIARIS;

EID: 72249104297     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2008.10.011     Document Type: Review

References (107)

1. Aguirre A., Center S.A., Randolph J., Yeager A., Keegan A., Harvey H., and Erb H. Gallbladder disease in Shetland Sheepdogs: 38 cases (1995-2005). Journal of the American Veterinary Medical Association 231 (2007) 79-88
2. Anderson N.V., and Low D.G. Diseases of the canine pancreas: a comparative summary of 103 cases. Animal Hospital 1 (1965) 189-194
3. Anderson N.V., and Strafuss A.C. Pancreatic disease in dogs and cats. Journal of the American Veterinary Medical Association 159 (1971) 885-891
4. Armstrong P.J., and Ford R.B. Hyperlipidemia. In: Kirk R.W. (Ed). Current Veterinary Therapy X (1989), WB Saunders, Philadelphia, Pennsylvania 1046-1050
5. Bailhache E., Nguyen P., Krempf M., Siliart B., Magot T., and Ouguerram K. Lipoproteins abnormalities in obese insulin-resistant dogs. Metabolism: Clinical and Experimental 52 (2003) 559-564
6. Barrie J., Watson T.D.G., Stear M.J., and Nash A.S. Plasma cholesterol and lipoprotein concentrations in the dog: the effects of age, breed, gender and endocrine disease. Journal of Small Animal Practice 34 (1993) 507-512
7. Bass V.D., Hoffman W.E., and Droner J.L. Normal canine lipid profiles and effects of experimentally induced pancreatitis and hepatic necrosis on lipids. American Journal of Veterinary Research 37 (1976) 1355-1357
8. Bauer J.E. Diet-induced alterations of lipoprotein metabolism. Journal of the American Veterinary Medical Association 201 (1992) 1691-1694
9. Bauer J.E. Evaluation and dietary considerations in idiopathic hyperlipidemia in dogs. Journal of the American Veterinary Medical Association 206 (1995) 1684-1688
10. Bauer J.E. Comparative lipid and lipoprotein metabolism. Veterinary Clinical Pathology 25 (1996) 49-56
11. Bauer J.E. Lipoprotein-mediated transport of dietary and synthesized lipids and lipid abnormalities of dogs and cats. Journal of the American Veterinary Medical Association 224 (2004) 668-675
12. Baum D. Congenital lipoprotein lipase deficiency and hyperlipemia in the young puppy. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 131 (1969) 183-185
13. Blomhoff J.P., Holme R., and Ostrem T. Plasma cholesterol esterification and plasma lipoproteins in bile-duct-ligated dogs. Scandinavian Journal of Gastroenterology 13 (1978) 693-702
14. Bodkin K. Seizures associated with hyperlipoproteinemia in a Miniature Schnauzer. Canine Practice 17 (1992) 11-15
15. Boland L.L., Folsom A.R., and Rosamond W.D. Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease: a prospective study. Annals of Epidemiology 12 (2002) 131-140
16. Burkhard M.J., and Meyer D.J. Causes and effects of interference with clinical laboratory measurements and examinations. In: Bonagura J.D. (Ed). Kirk's Current Veterinary Therapy XII (1995), WB Saunders, Philadelphia, Pennsylvania 14-20
17. Cameron J.L., Capuzzi D.M., Zuidema G.D., and Margolis S. Acute pancreatitis with hyperlipemia. Evidence for a persistent defect in lipid metabolism. American Journal of Medicine 56 (1974) 482-487
18. Center S.A., Smith C.A., Wilkinson E., Erb H.N., and Lewis R.M. Clinicopathological, renal immunofluorescent, and light microscopic features of glomerulonephritis in the dog - 41 Cases (1975-1985). Journal of the American Veterinary Medical Association 190 (1987) 81-90
19. Center S.A. Hepatic lipidosis, glucocorticoid hepatopathy, vacuolar hepatopathy, storage disorders, amyloidosis, and iron toxicity. In: Strombeck D.R., Guilford W.G., Center S.A., Williams D.A., and Meyer D.J. (Eds). Strombeck's Small Animal Gastroenterology (1996), WB Saunders, Philadelphia, Pennsylvania 766-801
20. Chikamune T., Katamoto H., Ohashi F., and Shimada Y. Serum lipid and lipoprotein concentrations in obese dogs. Journal of Veterinary Medical Science 57 (1995) 595-598
21. Chikamune T., Katamoto H., Nomura K., and Ohashi F. Lipoprotein profile in canine pancreatitis induced with oleic acid. Journal of Veterinary Medical Science 60 (1998) 413-421
22. Chuang J.H., Shieh C.S., Chang N.K., Chen W.J., and Lo S.K. Metabolic effect of parenteral nutrition in dogs with obstructive jaundice. Journal of the American College of Nutrition 14 (1995) 197-201
23. Connelly P.W. The role of hepatic lipase in lipoprotein metabolism. Clinica Chimica Acta 286 (1999) 243-255
24. Cook A.K., Breitschwerdt E.B., Levine J.F., Bunch S.E., and Linn L.O. Risk factors associated with acute pancreatitis in dogs: 101 cases (1985-1990). Journal of the American Veterinary Medical Association 203 (1993) 673-679
25. Cook A.K., and Cowgill L.D. Clinical and pathological features of protein-losing glomerular disease in the dog: a review of 137 cases (1985-1992). Journal of the American Animal Hospital Association 32 (1996) 313-322
26. Crispin S.M. Ocular manifestations of hyperlipoproteinemia. Journal of Small Animal Practice 34 (1993) 500-506
27. Danielsson B., Ekman R., Johansson B.G., and Petersson B.G. Plasma lipoprotein changes in experimental cholestasis in dog. Clinica Chimica Acta 80 (1977) 157-170
28. Deckelbaum R.J., Eisenberg S., Oschry Y., Butbul E., Sharon I., and Olivecrona T. Reversible modification of human plasma low-density lipoproteins toward triglyceride-rich precursors - a mechanism for losing excess cholesterol esters. Journal of Biological Chemistry 257 (1982) 6509-6517
29. Dibartola S.P., Tarr M.J., Parker A.T., Powers J.D., and Pultz J.A. Clinicopathologic findings in dogs with renal amyloidosis - 59 cases (1976-1986). Journal of the American Veterinary Medical Association 195 (1989) 358-364
30. Dibartola S.P., Tarr M.J., Webb D.M., and Giger U. Familial renal amyloidosis in Chinese Shar-Pei dogs. Journal of the American Veterinary Medical Association 197 (1990) 483-487
31. Diez M., Michaux C., Jeusette I., Baldwin P., Istasse L., and Biourge V. Evolution of blood parameters during weight loss in experimental obese Beagle dogs. Journal of Animal Physiology and Animal Nutrition 88 (2004) 166-171
32. Dixon R.M., Reid S.W., and Mooney C.T. Epidemiological, clinical, haematological and biochemical characteristics of canine hypothyroidism. Veterinary Record 145 (1999) 481-487
33. Downs L.G., Crispin S.M., Legrand-defretin V., PerezCamargo G., McCappin T., and Bolton C.H. The effect of dietary changes on plasma lipids and lipoproteins of six Labrador Retrievers. Research in Veterinary Science 63 (1997) 175-181
34. Elliott D.A. Dietary and medical considerations in hyperlipidemia. In: Ettinger S.J., and Feldman E.C. (Eds). Textbook of Veterinary Internal Medicine (2005), Saunders Elsevier, St. Louis, Missouri 592-595
35. Feldman E.C., and Nelson R.W. Canine and Feline Endocrinology and Reproduction (2004), Saunders, St. Louis, Missouri pp. 85-645
36. Ford R.B. Idiopathic hyperchylomicronemia in Miniature Schnauzers. Journal of Small Animal Practice 34 (1993) 488-492
37. Fielding C.J., and Fielding P.E. Molecular physiology of reverse cholesterol transport. Journal of Lipid Research 36 (1995) 211-228
38. Ford R.B. Clinical management of lipemic patients. Compendium on Continuing Education for the Practicing Veterinarian 18 (1996) 1053-1060
39. Fortson M.R., Freedman S.N., and Paul D. Clinical assessment of hyperlipidemic pancreatitis. American Journal of Gastroenterology 90 (1995) 2134-2139
40. Froyland L., Asiedu D.K., Vaagenes H., Garras A., Lie O., Totland G.K., and Berge R.K. Tetradecylthioacetic acid incorporated into very low density lipoprotein: changes in the fatty acid composition and reduced plasma lipids in cholesterol-fed hamsters. Journal of Lipid Research 36 (1995) 2529-2540
41. Ginsberg H.N. Lipoprotein physiology. Endocrinology and Metabolism Clinics of North America 27 (1998) 503-519
42. Gleeson J.M., Hejazi J.S., Kwong L., Chan I.F., Le T., Alberts A.W., and Wilson D.E. Plasma apolipoprotein-E, high-density lipoprotein-1 (Hdl1) and urinary mevalonate excretion in pancreatectomized diabetic dogs - effects of insulin and lovastatin. Atherosclerosis 84 (1990) 1-12
43. Goodhead B. Importance of nutrition in the pathogenesis of experimental pancreatitis in the dog. Archives of Surgery 103 (1971) 724-727
44. Guyton A.C., and Hall J.E. Digestion and absorption in the gastrointestinal tract. In: Guyton A.C., and Hall J.E. (Eds). Textbook of Medical Physiology (2000), WB Saunders, Philadelphia, Pennsylvania 754-763
45. Havel R.J. Pathogenesis, differentiation and management of hypertriglyceridemia. Advances in Internal Medicine 15 (1969) 117-154
46. Hess R.S., Saunders H.M., Van Winkle T.J., Shofer F.S., and Washabau R.J. Clinical, clinicopathologic, radiographic, and ultrasonographic abnormalities in dogs with fatal acute pancreatitis: 70 cases (1986-1995). Journal of the American Veterinary Medical Association 213 (1998) 665-670
47. Hess R.S., Kass P.H., Shofer F.S., Van Winkle T.J., and Washabau R.J. Evaluation of risk factors for fatal acute pancreatitis in dogs. Journal of the American Veterinary Medical Association 214 (1999) 46-51
48. Hess R.S., Saunders H.M., Van Winkle T.J., and Ward C.R. Concurrent disorders in dogs with diabetes mellitus: 221 cases (1993-1998). Journal of the American Veterinary Medical Association 217 (2000) 1166-1173
49. Hess R.S., Kass P.H., and Van Winkle T.J. Association between diabetes mellitus, hypothyroidism or hyperadrenocorticism, and atherosclerosis in dogs. Journal of Veterinary Internal Medicine 17 (2003) 489-494
50. Huang H.P., Yang H.L., Liang S.L., Lien Y.H., and Chen K.Y. Iatrogenic hyperadrenocorticism in 28 dogs. Journal of the American Animal Hospital Association 35 (1999) 200-207
51. Hubert B., Braun J.P., de la Farge F., and Mangol J.P. Hypertriglyceridemia in two related dogs. Companion Animal Practice 1 (1987) 33-35
52. Illingworth D.R., Connor W.E., Hatcher L.F., and Harris W.S. Hypolipemic effects of n-3 fatty-acids in primary hyperlipoproteinemia. Journal of Internal Medicine 225 (1989) 91-97
53. Jeusette I., Grauwels M., Cuvelier C., Tonglet C., Istasse L., and Diez M. Hypercholesterolaemia in a family of rough collie dogs. Journal of Small Animal Practice 45 (2004) 319-324
54. Jeusette I.C., Lhoest E.T., Istasse L.P., and Diez M.O. Influence of obesity on plasma lipid and lipoprotein concentrations in dogs. American Journal of Veterinary Research 66 (2005) 81-86
55. Johnson M.C. Hyperlipidemia disorders in dogs. Compendium on Continuing Education for the Practicing Veterinarian 27 (2005) 361-364
56. Jonas A. Lecithin cholesterol acyltransferase. Biochimica et Biophysica Acta 1529 (2000) 245-256
57. Kagawa Y., Hirayama K., Uchida E., Izumisawa Y., Yamaguchi M., Kotani T., Niiyama M., Yoshino T., and Taniyama H. Systemic atherosclerosis in dogs: histopathological and immunohistochemical studies of atherosclerotic lesions. Journal of Comparative Pathology 118 (1998) 195-206
58. Kashyap M.L., McGovern M.E., Berra K., Guyton J.R., Kwiterovich P.O., Harper W.L., Toth P.D., Favrot L.K., Kerzner B., Nash S.D., Bays H.E., and Simmons P.D. Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia. American Journal of Cardiology 89 (2002) 672-678
59. LeBlanc C.J., Bauer J.E., Hosgood G., and Mauldin G.E. Effect of dietary fish oil and vitamin E supplementation on hematologic and serum biochemical analytes and oxidative status in young dogs. Veterinary Therapeutics 6 (2005) 325-340
60. Lindsay S., Entenmann C., and Chaikoff I.L. Pancreatitis accompanying hepatic disease in dogs fed a high fat, low protein diet. A.M.A. Archives of Pathology 45 (1948) 635-638
61. Ling G.V., Stabenfeldt G.H., Comer K.M., Gribble D.H., and Schechter R.D. Canine hyperadrenocorticism: pretreatment clinical and laboratory evaluation of 117 cases. Journal of the American Veterinary Medical Association 174 (1979) 1211-1215
62. Littman M.P., Dambach D.M., Vaden S.L., and Giger U. Familial protein-losing enteropathy and protein-losing nephropathy in Soft Coated Wheaten Terriers: 222 cases (1983-1997). Journal of Veterinary Internal Medicine 14 (2000) 68-80
63. Liu S.K., Tilley L.P., Tappe J.P., and Fox P.R. Clinical and pathological findings in dogs with atherosclerosis - 21 cases (1970-1983). Journal of the American Veterinary Medical Association 189 (1986) 227-232
64. Logas D., Beale K.M., and Bauer J.E. Potential clinical benefits of dietary supplementation with marine-life oil. Journal of the American Veterinary Medical Association 199 (1991) 1631-1636
65. Mahley R.W., and Weisgraber K.H. Canine lipoproteins and atherosclerosis. I. Isolation and characterization of plasma lipoproteins from control dogs. Circulation Research 35 (1974) 713-721
66. Mahley R.W., Weisgraber K.H., and Innerarity T. Canine lipoproteins and atherosclerosis. II. Characterization of plasma lipoproteins associated with atherogenic and nonatherogenic hyperlipidemia. Circulation Research 35 (1974) 722-733
67. Mahley R.W., Innerarity T.L., Weisgraber K.H., and Fry D.L. Canine hyperlipoproteinemia and atherosclerosis: accumulation of lipid by aortic medial cells in-vivo and in-vitro. American Journal of Pathology 87 (1977) 205-225
68. Maldonado E.N., Romero J.R., Ochoa B., and Aveldano M.I. Lipid and fatty acid composition of canine lipoproteins. Comparative Biochemistry and Physiology B -Biochemistry and Molecular Biology 128 (2001) 719-729
69. Nelson R.W., Turnwald G.H., and Willard M.D. Endocrine, metabolic, and lipid disorders. In: Willard M.D., and Tvedten H. (Eds). Small Animal Clinical Diagnosis by Laboratory Methods (2004), Saunders St. Louis, Missouri 165-207
70. Nieto C.G., Barrera R., Habela M.A., Navarrete I., Molina C., Jimenez A., and Serrera J.L. Changes in the plasma concentrations of lipids and lipoprotein fractions in dogs infected with Leishmania infantum. Veterinary Parasitology 44 (1992) 175-182
71. Ogilvie G.K., Ford R.B., Vail D.M., Walters L.M., Salman M.D., Babineau C., and Fettman M.J. Alterations in lipoprotein profiles in dogs with lymphoma. Journal of Veterinary Internal Medicine 8 (1994) 62-66
72. Panciera D.L. Hypothyroidism in dogs: 66 cases (1987-1992). Journal of the American Veterinary Medical Association 204 (1994) 761-767
73. Pike F.S., Berg J., King N.W., Penninck D.G., and Webster C.R.L. Gallbladder mucocele in dogs: 30 cases (2000-2002). Journal of the American Veterinary Medical Association 224 (2004) 1615-1622
74. Rifai N., Bachorik P.S., and Albers J.J. Lipids, lipoproteins, and apolipoproteins. In: Burtis C.A., and Ashwood E.R. (Eds). Tietz Textbook of Clinical Chemistry (1999), WB Saunders, Philadelphia, Pennsylvania 809-861
75. Rogers W.A., Donovan E.F., and Kociba G.J. Idiopathic hyperlipoproteinemia in dogs. Journal of the American Veterinary Medical Association 166 (1975) 1087-1091
76. Rogers W.A., Donovan E.F., and Kociba G.J. Lipids and lipoproteins in normal dogs and in dogs with secondary hyperlipoproteinemia. Journal of the American Veterinary Medical Association 166 (1975) 1092-1100
77. Rogers W.A. Lipemia in the dog. Veterinary Clinics of North America Small Animal Practice 7 (1977) 637-647
78. Saharia P., Margolis S., Zuidema G.D., and Cameron J.L. Acute pancreatitis with hyperlipidemia: studies with an isolated perfused canine pancreas. Surgery 82 (1977) 60-67
79. Sato K., Agoh H., Kaneshige T., Hikasa W., and Kagota K. Hypercholesterolemia in Shetland Sheepdogs. Journal of Veterinary Medical Science 62 (2000) 1297-1301
80. Schenck P.A., Donovan D., Refsal K.N.R., and Rick M. Incidence of hypothyroidism in dogs with chronic hyperlipidemia. Journal of Veterinary Internal Medicine 18 (2004) 442
81. Scherk M.A., and Center S.A. Toxic, metabolic, infectious, and neoplastic liver diseases. In: Ettinger S.J., and Feldman E.C. (Eds). Textbook of Veterinary Internal Medicine (2005), Saunders Elsevier, St. Louis, Missouri 1464-1478
82. Schickel R. Identification of the nucleotide sequence of the lipoprotein lipase gene as well as its role in the development of hyperlipidemia and pancreatitis in the Miniature Schnauzer. (Dissertation) (2005), Ludwig-Maximilians University, Munich, Germany
83. Speck, L., 1865. Fall von lipamia. Arch Verin Wissenschaftl Heilkunde. Quoted in: Lipidoses, diseases of the intracellular lipid metabolism. In: Trannhauser, S.J. (Ed.), Grune and Stratton, New York, 1958, p. 307.
84. Spencer C.M., and Barradell L.B. Gemfibrozil - a reappraisal of its pharmacological properties and place in the management of dyslipidaemia. Drugs 51 (1996) 982-1018
85. Stalenhoef A.F.H., de Graaf J., Wittekoek M.E., Bredie S.J.H., Demacker P.N.M., and Kastelein J.J.P. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertrygliceridemia. Atherosclerosis 153 (2000) 129-138
86. Steiner J.M. Canine digestive lipases (Dissertation) (2000), Texas A&M University, Texas
87. Tidholm A., and Jonsson L. A retrospective study of canine dilated cardiomyopathy (189 cases). Journal of the American Animal Hospital Association 33 (1997) 544-550
88. Toskes P.P. Hyperlipidemic Pancreatitis. Gastroenterology Clinics of North America 19 (1990) 783-791
89. Tsutsumi K., Hagi A., and Inoue Y. The relationship between plasma high density lipoprotein cholesterol levels and cholesteryl ester transfer protein activity in six species of healthy experimental animals. Biological and Pharmaceutical Bulletin 24 (2001) 579-581
90. Vitale C.L., and Olby N.J. Neurologic dysfunction in hypothyroid, hyperlipidemic Labrador Retrievers. Journal of Veterinary Internal Medicine 21 (2007) 1316-1322
91. Wada M., Minamisono T., Ehrhart L.A., Naito H.K., and Mise J. Familial hyperlipoproteinemia in Beagles. Life Sciences 20 (1977) 999-1008
92. Walli A.K., and Seidel D. Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia: uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl co-enzyme-A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat. Journal of Clinical Investigation 74 (1984) 867-879
93. Wang C.S., and Hartsuck J. Structure and functional properties of lipoprotein lipase. Biochimica et Biophysica Acta 1123 (1992) 1-17
94. Watson P., Simpson K.W., and Bedford P.G.C. Hypercholesterolaemia in Briards in the United Kingdom. Research in Veterinary Science 54 (1993) 80-85
95. Watson T.D.G., and Barrie J. Lipoprotein metabolism and hyperlipemia in the dog and cat - a review. Journal of Small Animal Practice 34 (1993) 479-487
96. Whitney M.S., Boon G.D., Rebar A.H., and Ford R.B. Effects of acute pancreatitis on circulating lipids in dogs. American Journal of Veterinary Research 48 (1987) 1492-1497
97. Whitney M.S. Evaluation of hyperlipidemias in dogs and cats. Seminars in Veterinary Medicine and Surgery (Small Animal) 7 (1992) 292-300
98. Whitney M.S., Boon G.D., Rebar A.H., Story J.A., and Bottoms G.D. Ultracentrifugal and electrophoretic characteristics of the plasma lipoproteins of Miniature Schnauzer dogs with idiopathic hyperlipoproteinemia. Journal of Veterinary Internal Medicine 7 (1993) 253-260
99. Williams D.A. The Pancreas. In: Strombeck D.R., Guilford W.G., Center S.A., Williams D.A., and Meyer D.J. (Eds). Strombeck's Small Animal Gastroenterology (1996), WB Saunders, Philadelphia, Pennsylvania 381-410
100. Williams D.A., and Steiner J.M. Canine pancreatic disease. In: Ettinger S.J., and Feldman E.C. (Eds). Textbook of Veterinary Internal Medicine (2005), Saunders Elsevier, St. Louis, Missouri 1482-1488
101. Wilson D.E., Chan I.F., Elstad N.L., Pericgolia L., Hejazi J., Albu D.S., and Cutfield R. Apolipoprotein E-containing lipoproteins and lipoprotein remnants in experimental canine diabetes. Diabetes 35 (1986) 933-942
102. Xenoulis P.G., Suchodolski J.S., Ruaux C.G., Swim E.S., and Steiner J.M. Association between serum triglyceride and canine pancreatic lipase immunoreactivity (cPLI) concentrations in Miniature Schnauzers. Journal of Veterinary Internal Medicine 20 (2006) 750 (abstract)
103. Xenoulis P.G., Suchodolski J.S., Levinski M.D., and Steiner J.M. Investigation of hypertriglyceridemia in healthy Miniature Schnauzers. Journal of Veterinary Internal Medicine 21 (2007) 1224-1230
104. Xenoulis P.G., Suchodolski J.S., Levinski M.D., and Steiner J.M. Serum liver enzyme activities in healthy Miniature Schnauzers with and without hypertriglyceridemia. Journal of the American Veterinary Medical Association 232 (2008) 63-67
105. Yadav D., and Pitchumoni C.S. Issues in hyperlipidemic pancreatitis. Journal of Clinical Gastroenterology 36 (2003) 54-62
106. Yilmaz Z., and Senturk S. Characterization of lipid profiles in dogs with parvoviral enteritis. Journal of Small Animal Practice 48 (2007) 643-650 10.1111/j.1748-5827.2007.00391.x
107. Zafross M.K., and Dubielzig R.R. Solid intraocular xanthogranuloma in three Miniature Schnauzer dogs. Veterinary Ophthalmology 10 (2007) 304-307